News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
167,179 Results
Type
Article (7856)
Company Profile (109)
Press Release (159214)
Section
Business (57410)
Career Advice (259)
Deals (9929)
Drug Delivery (15)
Drug Development (22428)
Employer Resources (22)
FDA (4140)
Job Trends (4545)
News (91887)
Policy (6530)
Tag
Academia (596)
Accelerated approval (3)
Adcomms (4)
Allergies (26)
Alliances (8731)
ALS (19)
Alzheimer's disease (401)
Antibody-drug conjugate (ADC) (20)
Approvals (4189)
Artificial intelligence (58)
Autoimmune disease (8)
Automation (6)
Bankruptcy (50)
Best Places to Work (3757)
BIOSECURE Act (5)
Biosimilars (21)
Biotechnology (74)
Bladder cancer (28)
Brain cancer (8)
Breast cancer (103)
Cancer (703)
Cardiovascular disease (55)
Career advice (227)
Career pathing (3)
CAR-T (36)
Cell therapy (119)
Cervical cancer (12)
Clinical research (19491)
Collaboration (163)
Compensation (81)
Complete response letters (4)
COVID-19 (656)
CRISPR (12)
C-suite (24)
Cystic fibrosis (26)
Data (857)
Depression (11)
Diabetes (72)
Diagnostics (1695)
Digital health (3)
Diversity, equity & inclusion (7)
Drug discovery (33)
Drug pricing (13)
Drug shortages (6)
Duchenne muscular dystrophy (25)
Earnings (40124)
Editorial (7)
Employer branding (2)
Employer resources (21)
Events (25489)
Executive appointments (96)
FDA (4575)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (136)
Gene editing (30)
Generative AI (3)
Gene therapy (94)
GLP-1 (213)
Government (1010)
Grass and pollen (2)
Guidances (119)
Healthcare (5397)
Huntington's disease (9)
IgA nephropathy (12)
Immunology and inflammation (42)
Indications (11)
Infectious disease (690)
Inflammatory bowel disease (31)
Inflation Reduction Act (1)
Influenza (14)
Intellectual property (17)
Interviews (27)
IPO (6042)
IRA (4)
Job creations (1003)
Job search strategy (212)
Kidney cancer (3)
Labor market (11)
Layoffs (125)
Legal (1121)
Liver cancer (16)
Lung cancer (123)
Lymphoma (61)
Machine learning (3)
Management (6)
Manufacturing (86)
MASH (18)
Medical device (3515)
Medtech (3516)
Mergers & acquisitions (4110)
Metabolic disorders (183)
Multiple sclerosis (31)
NASH (5)
Neurodegenerative disease (22)
Neuropsychiatric disorders (2)
Neuroscience (543)
NextGen: Class of 2025 (1616)
Non-profit (1095)
Now hiring (5)
Obesity (97)
Opinion (32)
Ovarian cancer (26)
Pain (21)
Pancreatic cancer (21)
Parkinson's disease (39)
Partnered (6)
Patents (46)
Patient recruitment (26)
Peanut (14)
People (7541)
Pharmaceutical (29)
Pharmacy benefit managers (4)
Phase I (5013)
Phase II (8497)
Phase III (7481)
Pipeline (761)
Policy (22)
Postmarket research (741)
Preclinical (1558)
Press Release (21)
Prostate cancer (29)
Psychedelics (10)
Radiopharmaceuticals (40)
Rare diseases (113)
Real estate (1248)
Recruiting (10)
Regulatory (4938)
Reports (13)
Research institute (554)
Resumes & cover letters (25)
Rett syndrome (6)
RNA editing (2)
RSV (5)
Schizophrenia (22)
Series A (22)
Series B (10)
Service/supplier (2)
Sickle cell disease (16)
Special edition (7)
Spinal muscular atrophy (41)
Sponsored (8)
Startups (656)
Stomach cancer (4)
Supply chain (15)
Tariffs (13)
The Weekly (2)
Vaccines (175)
Venture capitalists (9)
Weight loss (55)
Women's health (4)
Worklife (3)
Date
Today (72)
Last 7 days (416)
Last 30 days (1027)
Last 365 days (9788)
2025 (3638)
2024 (10447)
2023 (11613)
2022 (14906)
2021 (15943)
2020 (14822)
2019 (12472)
2018 (9381)
2017 (8561)
2016 (7839)
2015 (9224)
2014 (6213)
2013 (4298)
2012 (4974)
2011 (5418)
2010 (4452)
Location
Africa (157)
Alabama (9)
Arizona (33)
Arkansas (1)
Asia (9796)
Australia (1730)
California (1895)
Canada (550)
China (154)
Colorado (74)
Connecticut (65)
Delaware (69)
Europe (23864)
Florida (269)
Georgia (64)
Idaho (9)
Illinois (154)
India (8)
Indiana (99)
Iowa (4)
Japan (51)
Kansas (24)
Kentucky (7)
Louisiana (5)
Maine (12)
Maryland (273)
Massachusetts (1382)
Michigan (55)
Minnesota (150)
Mississippi (1)
Missouri (16)
Montana (14)
Nebraska (3)
Nevada (36)
New Hampshire (29)
New Jersey (719)
New Mexico (4)
New York (528)
North Carolina (300)
Northern California (857)
Ohio (55)
Oklahoma (4)
Oregon (8)
Pennsylvania (381)
Rhode Island (10)
South America (293)
South Carolina (2)
South Dakota (1)
Southern California (750)
Tennessee (17)
Texas (263)
United States (7073)
Utah (62)
Virginia (27)
Washington D.C. (15)
Washington State (189)
West Virginia (1)
Wisconsin (23)
167,179 Results for "40".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Rallybio Downsizes by 40% After Dropping Lead Asset
The company discontinued development last month of its most mature asset, RLYB212, following disappointing mid-stage pharmacokinetic findings in a rare bleeding disorder.
May 9, 2025
·
2 min read
·
Tristan Manalac
Manufacturing
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans
In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing investments in the U.S., including Eli Lilly, Johnson & Johnson and Novartis. BMS is the latest to make a multibillion-dollar push.
May 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient
May 12, 2025
·
7 min read
Government
Trump Eyes $40 Billion Budget Cut for HHS: Reports
Despite these cuts, the FDA should be able to stay above a “trigger” level that would prevent it from collecting fees from the pharma industry and deprive it of approximately half of its annual funding, according to
The Washington Post.
April 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
FIELD MEDICAL CLOSES $40 MILLION SERIES A FINANCING TO REDEFINE PULSED FIELD ABLATION FOR VENTRICULAR TACHYCARDIA
April 21, 2025
·
3 min read
Press Releases
Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation
May 8, 2025
·
7 min read
Press Releases
Gene Editing Market Size to Exceed USD 40.10 Billion by 2034
February 26, 2025
·
1 min read
Press Releases
Zydus Receives Final Approval From USFDA for Glatiramer Acetate Injection, the Generic Version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
May 8, 2025
·
3 min read
Press Releases
Alterity Therapeutics Raises A$40.0 million in Placement
February 10, 2025
·
6 min read
Press Releases
Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 With Key Innovative Medicines Growing ~40%; 2025 Profit Outlook Improved
May 7, 2025
·
50 min read
1 of 16,718
Next
